Russell Investments Group, Ltd. Oramed Pharmaceuticals Inc. Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$2.07 - $2.83 $517 - $707	250 New	250 $0
Q4 2022 Feb 08, 2023	BUY	$5.88 - $12.03 $332,314 - $679,887	56,516 New	56,516 $679,000
Q2 2022 Jul 29, 2022	SELL	$3.72 - $9.0 $160,008 - $387,117	-43,013 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$8.19 - $13.89 $443,054 - $751,407	-54,097 Reduced 55.71%	43,013 $371,000
Q4 2021 Jan 21, 2022	SELL	$12.98 - $29.75 $74,803 - $171,449	-5,763 Reduced 5.6%	97,110 $1.39 Million
Q3 2021 Nov 08, 2021	BUY	$12.13 - $23.82 $1.25 Million - $2.45 Million	102,873 New	102,873 $2.26 Million

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.